Prelude Therapeutics Incorporated Common Stock (PRLD)

Typically moves ±7.58% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-08-13 APPROXIMATE
search

Since Aug 12, 2021, Prelude Therapeutics Incorporated Common Stock (PRLD) has reported earnings 20 times. On average the shares move ±7.58% post-earnings, with a positive reaction 50.0% of the time. Its largest post-earnings gain was +32.71% (Feb 15, 2024) and its largest decline was -7.02% (Nov 14, 2022). The next earnings report is predicted for 2026-08-13 (approximate).

Earnings reactions

How PRLD moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±7.58%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 12, 2026 ☀ PRE -3.33% open_in_new
Mar 10, 2026 ☀ PRE +16.29% open_in_new
Nov 12, 2025 ☀ PRE +8.15% open_in_new
Aug 14, 2025 ☀ PRE +1.14% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.58%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 12 →
12
Funds holding
$3949848
Total value held
Buying
8 added · 2 reduced
Morgan Stanley
$1101790 -3.81%
Blackrock, Inc.
$1100850 +20.88%
Goldman Sachs Group Inc
$808724 +101.29%
State Street Corp
$472750 +8.59%
Bank Of America Corp /De/
$193316 +476.32%

Frequently asked about PRLD earnings

When does Prelude Therapeutics Incorporated Common Stock report earnings next? expand_more

Prelude Therapeutics Incorporated Common Stock (PRLD)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does PRLD stock move after earnings? expand_more

Over 20 reports, PRLD has moved an average of ±7.58% the session after earnings, closing higher 50.0% of the time.

What was PRLD's biggest post-earnings move? expand_more

PRLD's largest post-earnings gain on record was +32.71% on Feb 15, 2024, and its largest decline was -7.02% on Nov 14, 2022.

Where can I find Prelude Therapeutics Incorporated Common Stock's SEC filings? expand_more

All of Prelude Therapeutics Incorporated Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.